186 related articles for article (PubMed ID: 31819140)
1. Early antibody response and clinical outcome in experimental canine leishmaniasis.
Olías-Molero AI; Corral MJ; Jiménez-Antón MD; Alunda JM
Sci Rep; 2019 Dec; 9(1):18606. PubMed ID: 31819140
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the humoral immune response against total and recombinant antigens of Leishmania infantum: correlation with disease progression in canine experimental leishmaniasis.
Nieto CG; García-Alonso M; Requena JM; Mirón C; Soto M; Alonso C; Navarrete I
Vet Immunol Immunopathol; 1999 Feb; 67(2):117-30. PubMed ID: 10077418
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of the Leishmania infantum-specific antibody repertoires and the autoantibody repertoires between asymptomatic and symptomatic dogs.
Chaabouni A; Boubaker Elandoulsi R; Mhadhbi M; Gharbi M; Sassi A
Vet Parasitol; 2018 Sep; 261():9-17. PubMed ID: 30253856
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of new Leishmania promastigote surface antigens, LaPSA-38S and LiPSA-50S, as major immunodominant excreted/secreted components of L. amazonensis and L. infantum.
Bras-Gonçalves R; Petitdidier E; Pagniez J; Veyrier R; Cibrelus P; Cavaleyra M; Maquaire S; Moreaux J; Lemesre JL
Infect Genet Evol; 2014 Jun; 24():1-14. PubMed ID: 24614507
[TBL] [Abstract][Full Text] [Related]
5. Effect of the preservative and temperature conditions on the stability of Leishmania infantum promastigotes antigens applied in a flow cytometry diagnostic method for canine visceral leishmaniasis.
Gama Ker H; Dian de Oliveira Aguiar-Soares R; Mendes Roatt B; das Dores Moreira N; Coura-Vital W; Martins Carneiro C; Teixeira-Carvalho A; Martins-Filho OA; Cordeiro Giunchetti R; da Silveira-Lemos D; Barbosa Reis A
Diagn Microbiol Infect Dis; 2013 Aug; 76(4):470-6. PubMed ID: 23726649
[TBL] [Abstract][Full Text] [Related]
6. Recombinant Forms of Leishmania amazonensis Excreted/Secreted Promastigote Surface Antigen (PSA) Induce Protective Immune Responses in Dogs.
Petitdidier E; Pagniez J; Papierok G; Vincendeau P; Lemesre JL; Bras-Gonçalves R
PLoS Negl Trop Dis; 2016 May; 10(5):e0004614. PubMed ID: 27223609
[TBL] [Abstract][Full Text] [Related]
7. Serological evaluation of experimentally infected dogs by LicTXNPx-ELISA and amastigote-flow cytometry.
Silvestre R; Santarém N; Cunha J; Cardoso L; Nieto J; Carrillo E; Moreno J; Cordeiro-da-Silva A
Vet Parasitol; 2008 Nov; 158(1-2):23-30. PubMed ID: 18848397
[TBL] [Abstract][Full Text] [Related]
8. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
[TBL] [Abstract][Full Text] [Related]
9. Immune response against Leishmania antigens in dogs naturally and experimentally infected with Leishmania infantum.
Rhalem A; Sahibi H; Guessous-Idrissi N; Lasri S; Natami A; Riyad M; Berrag B
Vet Parasitol; 1999 Mar; 81(3):173-84. PubMed ID: 10190861
[TBL] [Abstract][Full Text] [Related]
10. Humoral and cell-mediated immunity in natural and experimental canine leishmaniasis.
Martínez-Moreno A; Moreno T; Martínez-Moreno FJ; Acosta I; Hernández S
Vet Immunol Immunopathol; 1995 Oct; 48(3-4):209-20. PubMed ID: 8578681
[TBL] [Abstract][Full Text] [Related]
11. Follow-up of Leishmania infantum naturally infected dogs treated with allopurinol: immunofluorescence antibody test, ELISA and Western blot.
Vercammen F; Fernandez-Perez FJ; del Amo C; Alunda JM
Acta Trop; 2002 Dec; 84(3):175-81. PubMed ID: 12443795
[TBL] [Abstract][Full Text] [Related]
12. Cell mediated immunity and specific IgG1 and IgG2 antibody response in natural and experimental canine leishmaniosis.
Leandro C; Santos-Gomes GM; Campino L; Romão P; Cortes S; Rolão N; Gomes-Pereira S; Riça Capela MJ; Abranches P
Vet Immunol Immunopathol; 2001 May; 79(3-4):273-84. PubMed ID: 11389961
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Leishmania recombinant K39 antigen as a diagnostic marker for canine leishmaniasis and validation of a standardized enzyme-linked immunosorbent assay.
Scalone A; De Luna R; Oliva G; Baldi L; Satta G; Vesco G; Mignone W; Turilli C; Mondesire RR; Simpson D; Donoghue AR; Frank GR; Gradoni L
Vet Parasitol; 2002 Apr; 104(4):275-85. PubMed ID: 11836028
[TBL] [Abstract][Full Text] [Related]
14. Kinetics and diagnostic and prognostic potential of quantitative Western blot analysis and antigen-specific enzyme-linked immunosorbent assay in experimental canine leishmaniasis.
Talmi-Frank D; Strauss-Ayali D; Jaffe CL; Baneth G
Clin Vaccine Immunol; 2006 Feb; 13(2):271-6. PubMed ID: 16467337
[TBL] [Abstract][Full Text] [Related]
15. During canine leishmaniasis a protein belonging to the 83-kDa heat-shock protein family elicits a strong humoral response.
Angel SO; Requena JM; Soto M; Criado D; Alonso C
Acta Trop; 1996 Sep; 62(1):45-56. PubMed ID: 8971277
[TBL] [Abstract][Full Text] [Related]
16. Identification of antibodies to Leishmania silent information regulatory 2 (SIR2) protein homologue during canine natural infections: pathological implications.
Cordeiro-da-Silva A; Cardoso L; Araújo N; Castro H; Tomás A; Rodrigues M; Cabral M; Vergnes B; Sereno D; Ouaissi A
Immunol Lett; 2003 Apr; 86(2):155-62. PubMed ID: 12644317
[TBL] [Abstract][Full Text] [Related]
17. A novel exo-antigen-based ELISA for the detection of canine leishmaniasis.
Rajasekariah GH; Cardoso L; Dogcio DA; Martin SK; Smithyman AM
Am J Trop Med Hyg; 2008 Apr; 78(4):616-23. PubMed ID: 18385358
[TBL] [Abstract][Full Text] [Related]
18. Antibody response in dogs experimentally infected with Leishmania infantum: infection course antigen markers.
Carrera L; Fermín ML; Tesouro M; García P; Rollán E; González JL; Méndez S; Cuquerella M; Alunda JM
Exp Parasitol; 1996 Mar; 82(2):139-46. PubMed ID: 8617340
[TBL] [Abstract][Full Text] [Related]
19. Challenges in the serological evaluation of dogs clinically suspect for canine leishmaniasis.
Santarém N; Sousa S; Amorim CG; de Carvalho NL; de Carvalho HL; Felgueiras Ó; Brito M; da Silva AC
Sci Rep; 2020 Feb; 10(1):3099. PubMed ID: 32080327
[TBL] [Abstract][Full Text] [Related]
20. Recombinant Leishmania eukaryotic elongation factor-1 beta protein: A potential diagnostic antigen to detect tegumentary and visceral leishmaniasis in dogs and humans.
Santos TTO; Cardoso MS; Machado AS; Siqueira WF; Ramos FF; Oliveira-da-Silva JA; Tavares GSV; Lage DP; Costa LE; de Freitas CS; Martins VT; Bandeira RS; Chávez-Fumagalli MA; Lyon S; Moreira RLF; de Magalhães-Soares DF; Silveira JAG; Tupinambás U; Caligiorne RB; Chaves AT; Rocha MOC; Fujiwara RT; Coelho EAF
Microb Pathog; 2019 Dec; 137():103783. PubMed ID: 31600536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
